136 related articles for article (PubMed ID: 12479242)
1. Hypertrophic phenotype of cardiac calcium/calmodulin-dependent protein kinase II is reversed by angiotensin converting enzyme inhibition.
Hempel P; Hoch B; Bartel S; Karczewski P
Basic Res Cardiol; 2002; 97 Suppl 1():I96-101. PubMed ID: 12479242
[TBL] [Abstract][Full Text] [Related]
2. Expression of Ca2+/calmodulin-dependent protein kinase II delta-subunit isoforms in rats with hypertensive cardiac hypertrophy.
Hagemann D; Bohlender J; Hoch B; Krause EG; Karczewski P
Mol Cell Biochem; 2001 Apr; 220(1-2):69-76. PubMed ID: 11451385
[TBL] [Abstract][Full Text] [Related]
3. Cardiac mitogen-activated protein kinase activities are chronically increased in stroke-prone hypertensive rats.
Izumi Y; Kim S; Murakami T; Yamanaka S; Iwao H
Hypertension; 1998 Jan; 31(1):50-6. PubMed ID: 9449390
[TBL] [Abstract][Full Text] [Related]
4. Molecular mechanism of angiotensin II type I and type II receptors in cardiac hypertrophy of spontaneously hypertensive rats.
Makino N; Sugano M; Otsuka S; Hata T
Hypertension; 1997 Oct; 30(4):796-802. PubMed ID: 9336375
[TBL] [Abstract][Full Text] [Related]
5. Angiotensin II type 1 receptor antagonist and angiotensin-converting enzyme inhibitor altered the activation of Cu/Zn-containing superoxide dismutase in the heart of stroke-prone spontaneously hypertensive rats.
Tanaka M; Umemoto S; Kawahara S; Kubo M; Itoh S; Umeji K; Matsuzaki M
Hypertens Res; 2005 Jan; 28(1):67-77. PubMed ID: 15969257
[TBL] [Abstract][Full Text] [Related]
6. A newly developed angiotensin II type 1 receptor antagonist, CS866, promotes regression of cardiac hypertrophy by reducing integrin beta1 expression.
Jia N; Okamoto H; Shimizu T; Chiba S; Matsui Y; Sugawara T; Akino M; Kitabatake A
Hypertens Res; 2003 Sep; 26(9):737-42. PubMed ID: 14620930
[TBL] [Abstract][Full Text] [Related]
7. Captopril modifies gene expression in hypertrophied and failing hearts of aged spontaneously hypertensive rats.
Brooks WW; Bing OH; Conrad CH; O'Neill L; Crow MT; Lakatta EG; Dostal DE; Baker KM; Boluyt MO
Hypertension; 1997 Dec; 30(6):1362-8. PubMed ID: 9403554
[TBL] [Abstract][Full Text] [Related]
8. Effect of calcium channel blockade or angiotensin-converting enzyme inhibition on structure of coronary, renal, and other small arteries in spontaneously hypertensive rats.
Li JS; Schiffrin EL
J Cardiovasc Pharmacol; 1996 Jul; 28(1):68-74. PubMed ID: 8797138
[TBL] [Abstract][Full Text] [Related]
9. Cyclin-Dependent Kinase Inhibitor p21WAF1/CIP1 Facilitates the Development of Cardiac Hypertrophy.
Tong YF; Wang Y; Ding YY; Li JM; Pan XC; Lu XL; Chen XH; Liu Y; Zhang HG
Cell Physiol Biochem; 2017; 42(4):1645-1656. PubMed ID: 28746924
[TBL] [Abstract][Full Text] [Related]
10. Important role of angiotensin II-mediated c-Jun NH(2)-terminal kinase activation in cardiac hypertrophy in hypertensive rats.
Izumi Y; Kim S; Zhan Y; Namba M; Yasumoto H; Iwao H
Hypertension; 2000 Oct; 36(4):511-6. PubMed ID: 11040228
[TBL] [Abstract][Full Text] [Related]
11. The cardiac-specific nuclear delta(B) isoform of Ca2+/calmodulin-dependent protein kinase II induces hypertrophy and dilated cardiomyopathy associated with increased protein phosphatase 2A activity.
Zhang T; Johnson EN; Gu Y; Morissette MR; Sah VP; Gigena MS; Belke DD; Dillmann WH; Rogers TB; Schulman H; Ross J; Brown JH
J Biol Chem; 2002 Jan; 277(2):1261-7. PubMed ID: 11694533
[TBL] [Abstract][Full Text] [Related]
12. Ras and rho are required for galphaq-induced hypertrophic gene expression in neonatal rat cardiac myocytes.
Hines WA; Thorburn A
J Mol Cell Cardiol; 1998 Mar; 30(3):485-94. PubMed ID: 9515026
[TBL] [Abstract][Full Text] [Related]
13. Relationship between cardiovascular hypertrophy and cardiac baroreflex function in spontaneously hypertensive and stroke-prone rats.
Minami N; Head GA
J Hypertens; 1993 May; 11(5):523-33. PubMed ID: 8390524
[TBL] [Abstract][Full Text] [Related]
14. Differential regulation of cardiac adrenomedullin and natriuretic peptide gene expression by AT1 receptor antagonism and ACE inhibition in normotensive and hypertensive rats.
Magga J; Kalliovalkama J; Romppanen H; Vuolteenaho O; Pörsti I; Kähönen M; Tolvanen JP; Ruskoaho H
J Hypertens; 1999 Nov; 17(11):1543-52. PubMed ID: 10608466
[TBL] [Abstract][Full Text] [Related]
15. Effects of chronic treatment with a novel angiotensin converting enzyme inhibitor, CS622, and a vasodilator, hydralazine, on atrial natriuretic factor (ANF) in spontaneously hypertensive rats (SHR).
Oda T; Iijima Y; Sada T; Nishino H; Oizumi K; Koike H
Biochem Biophys Res Commun; 1988 Apr; 152(1):456-62. PubMed ID: 2833897
[TBL] [Abstract][Full Text] [Related]
16. Effects of alatriopril, a mixed inhibitor of atriopeptidase and angiotensin I-converting enzyme, on cardiac hypertrophy and hormonal responses in rats with myocardial infarction. Comparison with captopril.
Bralet J; Marie C; Mossiat C; Lecomte JM; Gros C; Schwartz JC
J Pharmacol Exp Ther; 1994 Jul; 270(1):8-14. PubMed ID: 8035346
[TBL] [Abstract][Full Text] [Related]
17. Identification and expression of delta-isoforms of the multifunctional Ca2+/calmodulin-dependent protein kinase in failing and nonfailing human myocardium.
Hoch B; Meyer R; Hetzer R; Krause EG; Karczewski P
Circ Res; 1999 Apr; 84(6):713-21. PubMed ID: 10189359
[TBL] [Abstract][Full Text] [Related]
18. Cardiac aldosterone production in genetically hypertensive rats.
Takeda Y; Yoneda T; Demura M; Miyamori I; Mabuchi H
Hypertension; 2000 Oct; 36(4):495-500. PubMed ID: 11040225
[TBL] [Abstract][Full Text] [Related]
19. [Expression of mitogen-activated protein kinase in hypertrophic myocardium in SHRsp].
Wang M; Wang T; Liu L
Zhonghua Yi Xue Za Zhi; 1997 Sep; 77(9):680-2. PubMed ID: 9772538
[TBL] [Abstract][Full Text] [Related]
20. Cardiovascular effects of combination of perindopril, candesartan, and amlodipine in hypertensive rats.
Kim S; Zhan Y; Izumi Y; Iwao H
Hypertension; 2000 Mar; 35(3):769-74. PubMed ID: 10720593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
